Comprehensive N-Glycan Profiling of Cetuximab Biosimilar Candidate by NP-HPLC and MALDI-MS
Sheng Liu(Wuhan National Laboratory for Optoelectronics), Xin Liu(Wuhan National Laboratory for Optoelectronics), Yao Wang(Xuzhou Medical College), Xiaojun Feng(Wuxi People's Hospital), Zhenyu He(Wuhan Center for Disease Control and Prevention), Wenjie Gao(Wuhan National Laboratory for Optoelectronics), Bi‐Feng Liu(Wuhan National Laboratory for Optoelectronics)
Cited by 31
Related Papers
Smartphone-based platforms implementing microfluidic detection with image-based artificial intelligence
|Nature Communications|2023|248
Chemically Edited Exosomes with Dual Ligand Purified by Microfluidic Device for Active Targeted Drug Delivery to Tumor Cells
|ACS Applied Materials & Interfaces|2017|218
Designer Exosomes for Active Targeted Chemo‐Photothermal Synergistic Tumor Therapy
|Advanced Functional Materials|2018|188
The use of RGD-engineered exosomes for enhanced targeting ability and synergistic therapy toward angiogenesis
|Nanoscale|2017|164
Designer exosomes enabling tumor targeted efficient chemo/gene/photothermal therapy
|Biomaterials|2021|136